翰森制药口服 GLP-1R 激动剂启动肥胖 II 期临床

Insight数据库
May 07, 2025

5 月 6 日,翰森制药在药物临床试验登记与信息公示平台上登记了一项在超重和肥胖受试者中评估每天一次口服 HS-10501/HS-10501-2 的有效性和安全性的多中心、随机、双盲、安慰剂对照的 Ⅱ 期临床研究。来源:药物临床试验登记与信息公示平台官网这是一项多中心、随机、双盲、安慰剂对照的 II 期临床研究,旨在超重伴有至少 1 种体重相关合并症和肥胖的成人受试者中评估每天一次口服 HS-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10